574 related articles for article (PubMed ID: 21478152)
1. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
2. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.
Wang T; Kusudo T; Takeuchi T; Yamashita Y; Kontani Y; Okamatsu Y; Saito M; Mori N; Yamashita H
PLoS One; 2013; 8(12):e83264. PubMed ID: 24391749
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
[TBL] [Abstract][Full Text] [Related]
4. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
5. Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.
Hançer NJ; Qiu W; Cherella C; Li Y; Copps KD; White MF
J Biol Chem; 2014 May; 289(18):12467-84. PubMed ID: 24652289
[TBL] [Abstract][Full Text] [Related]
6. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling.
Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
Free Radic Biol Med; 2015 May; 82():137-46. PubMed ID: 25617592
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P
PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163
[TBL] [Abstract][Full Text] [Related]
8. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.
Copps KD; Hançer NJ; Qiu W; White MF
J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Ning J; Clemmons DR
Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
[TBL] [Abstract][Full Text] [Related]
10. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.
Kimura N; Tokunaga C; Dalal S; Richardson C; Yoshino K; Hara K; Kemp BE; Witters LA; Mimura O; Yonezawa K
Genes Cells; 2003 Jan; 8(1):65-79. PubMed ID: 12558800
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
[TBL] [Abstract][Full Text] [Related]
12. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
Cai ZF; Deng L; Wang MM; Zhang JQ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966
[No Abstract] [Full Text] [Related]
13. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
14. GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis.
Liao H; Gao W; Ma J; Xue H; Wang Y; Huang D; Yan F; Ye Y
Cell Biol Int; 2021 Jun; 45(6):1211-1219. PubMed ID: 33554444
[TBL] [Abstract][Full Text] [Related]
15. Role of resistin in cardiac contractility and hypertrophy.
Kim M; Oh JK; Sakata S; Liang I; Park W; Hajjar RJ; Lebeche D
J Mol Cell Cardiol; 2008 Aug; 45(2):270-80. PubMed ID: 18597775
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle.
Chopra I; Li HF; Wang H; Webster KA
Diabetologia; 2012 Mar; 55(3):783-94. PubMed ID: 22207502
[TBL] [Abstract][Full Text] [Related]
17. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
[TBL] [Abstract][Full Text] [Related]
18. The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors.
Ola A; Kerkelä R; Tokola H; Pikkarainen S; Skoumal R; Vuolteenaho O; Ruskoaho H
Br J Pharmacol; 2010 Feb; 159(3):717-25. PubMed ID: 20067472
[TBL] [Abstract][Full Text] [Related]
19. Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo.
Longnus SL; Ségalen C; Giudicelli J; Sajan MP; Farese RV; Van Obberghen E
Diabetologia; 2005 Dec; 48(12):2591-601. PubMed ID: 16283248
[TBL] [Abstract][Full Text] [Related]
20. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
